CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study seeks to determine the effectiveness of Rucaparib as maintenance therapy for metastatic and recurrent endometrial cancer...
Phase 2
Aurora, Colorado, United States
Study RGX-104-001 is a Phase 1, first-in-human, dose escalation and expansion study of RGX-104, an oral small molecule targeting the liver X receptor...
Phase 1
Aurora, Colorado, United States and 20 other locations
Phase 1 trial to study the safety, pharmacokinetics and preliminary efficacy of STRO-002 given intravenously every 3 weeks.
Phase 1
Aurora, Colorado, United States and 26 other locations
IMGN151-1001 is a Phase 1, first in human, open-label dose-escalation and expansion study in adult patients with recurrent endometrial cancer...
Phase 1
Aurora, Colorado, United States and 5 other locations
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
Aurora, Colorado, United States and 202 other locations
compared to Tamoxifen and Medroxyprogesterone acetate in treating endometrial cancer and to determine the types and severity of sid...
Phase 2
Aurora, Colorado, United States and 25 other locations
Phase.Cohort A: Advanced or Metastatic Triple Negative Breast Cancer (TNBC) (IO-treated)Cohort B: Advanced or Metastatic Triple Negative Bre ...
Phase 1, Phase 2
Aurora, Colorado, United States and 15 other locations
This is an open-label, non-randomized, Phase 1b/2 study to determine the safety and tolerability of NC410 when combined with a standard dose of pembr...
Phase 1, Phase 2
Aurora, Colorado, United States and 16 other locations
preliminary antitumor activity of NKT3447 in adult subjects with cyclin E1 (CCNE1) amplified ovarian cancer at the RDEs selected in Dose Es...
Phase 1
Denver, Colorado, United States and 4 other locations
This study is an open-label, Phase 1, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) profile...
Phase 1
Aurora, Colorado, United States and 18 other locations
Clinical trials
Research sites
Resources
Legal